LIMCOPRIN SL
Company details
- Active NIF/CIF: B74075896
-
Telephone: Not available
-
Date of last BORME entry: 04/01/2008
-
Sector: Human Health and Social Work Activities
-
Address: Calle Palmira Villa, número 5, 6ºH (OVIEDO)
-
Website: Not available
-
Featured products:
More information on LIMCOPRIN SL
-
04/01/2008 | BORME act no.: 1936 | Register: ASTURIASDepósito de cuentas anuales (Diciembre de 2007) -
15/12/2006 | BORME act no.: 1027162 | Register:Depósito de cuentas anuales (Diciembre de 2006)
-
18/01/2006 | BORME act no.: 31123 | Register: ASTURIASDepósito de cuentas anuales (Diciembre de 2005)
-
23/10/2003 | BORME act no.: 398337 | Register: ASTURIASConstitución
-
23/10/2003 | BORME act no.: 398337 | Register: ASTURIASNombramientos
Other information
The CIF assigned to LIMCOPRIN SL is B74075896, while its current business status is active. The company operates in the economic sector identified by the CNAE 8610 - Hospital activities. In addition, its activity corresponds to the SIC classification 8062 - Hospitales de medicina general y cirugía.
The template of LIMCOPRIN SL includes Between 10 and 49 employees, and the company reports an annual turnover of less than 2 million euros. LIMCOPRIN SL is registered in the Mercantile Registry of Asturias and accumulates a total of 2 registration charges. The most recent announcement in Borme was published on 04/01/2008, while its last deposit of ordinary annual accounts is related to the - exercise.
If you want to obtain contact information for LIMCOPRIN SL, such as the telephone number, postal address, or website, you can consult our Company Data module.
To access more details about LIMCOPRIN SL, consider reviewing one of our available financial reports, the company's Annual Accounts, or verifying its outstanding payments registered in the RAI delinquency file.
The financial, commercial, and legal information provided about LIMCOPRIN SL comes from official data sources and is automatically updated every day.
Do you want to know more about LIMCOPRIN SL??
Find out more about this company by consulting these reports:
